Cardiovascular Diseases

Taking BP-lowering Drugs at Night Beneficial

A multicenter, controlled, prospective endpoint trial confirmed that routinely taking blood pressure (BP)-lowering medications at bedtime, as opposed to upon waking, resulted in improved ambulatory BP control (significantly enhanced decrease in asleep BP and increased sleep-time relative BP decline, i.e. BP dipping) and markedly reduced major cardiovascular disease (CVD) events. The trial included 19 084 hypertensive patients (10 614 men/8470 women, 60.5 ± 13.7 years of age) assigned (1:1) to take the entire daily dose of ≥1 hypertension medications at bedtime (n = 9552) or all of them upon awakening (n = 9532). At inclusion and at every scheduled clinic visit (at least annually) throughout follow-up, ambulatory BP monitoring was performed for 48 h. During a 6.3-year median follow-up, 1752 patients experienced the primary CVD outcome. Adjusted for significant influential characteristics, patients of the bedtime, compared with the upon-waking, treatment-time regimen showed significantly lower hazard ratio of the primary CVD outcome (0.55) and each of its single components, i.e. CVD death (0.44), myocardial infarction (0.66), coronary revascularization (0.60), heart failure (0.58), and stroke (0.51). The bedtime treatment was at least as safe, and with similar patient compliance and adherence, as usual upon-waking treatment. The findings are consistent with previous studies. Source: https://academic.oup.com/eurheartj/

hyangiu

Recent Posts

Dose Response of Physical Activity in CVD and Mortality

Two recent studies highlight the importance of physical activity volume and intensity in reducing cardiovascular…

1 day ago

Faster Walking Pace May Reduce Risk of Cardiac Arrhythmias

A prospective UK cohort study found that both self-reported average or brisk walking pace and…

2 days ago

4:3 Intermittent Fasting Outperforms Daily Caloric Restriction for Weight Loss

A U.S. randomized clinical trial found that 4:3 intermittent fasting (IMF) led to slightly greater…

4 weeks ago

Comparative CVD Efficacy of Newer Glucose-Lowering Drugs in Elderly T2D Patients

A Danish nationwide cohort study provided real world evidence that both glucagon-like peptide 1 receptor…

1 month ago

Efficacy of Non-Surgical and Non-Interventional Treatments in Low Back Pain

A systematic review and meta-analysis of placebo-controlled randomized trials showed that there is moderate certainty…

1 month ago

Statin Use Linked to Lower Risks of HCC and Liver Disease Progression

A US cohort study indicated that statin use may reduce the risks of hepatocellular carcinoma…

1 month ago

This website uses cookies.